Article Listing - Genentech sales rise thanks to Herceptin and Rituxan, takes $1.15 billion

REDUCING ASTHMA COSTS IN THE USA

6 April 1992

A study looking at the economic aspect of asthma in the USA has found that there are a number of...

ICN-GALENIKA "HEALTHY SHARES"

6 April 1992

Yugoslavia's Tanjug news agency reports that Milan Panic, head of ICN-Galenika and founder of US-based ICN Pharmaceuticals, is saying the...

AUSTRALIAN DRUG PROMOTION STUDY

6 April 1992

In Australia, a parliamentary report from the House of Representatives concludes that there is no evidence that hospitality provided...

MG FRANCE ATTACKS GOVT COST-CUTTING

6 April 1992

The association of doctors in France, MG France, has attacked the agreement on health care expenditures which has been...

MILES STAFF CUTS

6 April 1992

Miles Inc of the USA is to reduce its workforce at its Diagnostics Business Group by 600, around 9%. The...

MGI PHARMA'S SALAGEN

6 April 1992

MGI Pharma has gained orphan drug status from the US Food and Drug Administration for Salagen (pilocarpine), to treat dry...

PFIZER'S DIFLUCAN

6 April 1992

Prophylactic administration of Pfizer's Diflucan (fluconazole) to recipients of autologous bone marrow transplants reduces the incidence of both systemic and...

Mexican Health Ministry Merges

6 April 1992

In a major shake-up within the Mexican administration, the government is proposing to merge the Ministry of Health with the...

STOCK MARKET COMMENTARY: EUROPE

6 April 1992

EUROPE: saw most bourses weak at the start of the reporting period, but strengthen as time went on. By the...

NIGERIAN HEALTH SPENDING FOR 1992

6 April 1992

The federal government of Nigeria has announced a total figure for health care spending in 1992 of 192 million naira,...

Showing 94431-94440 of 95329 articles